Data search
Results for MligTC455_39100
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_39100 | 62 | 1.29 | Mlig455_009476 | Neo: - Age: Down-Up-Down Region-enriched R4: 3.504/0.03677 |
CABP7 | Mlig455_009476 {REF} {Length: 960} {Pfam: EF hand [PF00036.34, score=45.6]; EF-hand domain [PF13405.8, score=35.6]; EF-hand domain pair [PF13499.8, score=30.4]; EF-hand domain pair [PF13833.8, score=29.2]; EF hand [PF13202.8, score=28.1]} {Human: ENSG00000100314, CABP7, calcium binding protein 7, [Score=46.6, Expect=1e-05]} {Mouse: ENSMUSG00000009075, Cabp7, calcium binding protein 7, [Score=46.6, Expect=8e-06]} {Celegans: WBGene00015264, B0563.7, Uncharacterized calcium-binding protein B0563.7, [Score=50.4, Expect=3e-07]} {Smed: dd_Smed_v6_13677_0_1, dd_Smed_v6_13677_0_1, [RH, Score=185, Expect=1e-57]} {RNA1509_25282} {RNA1310_29885.1} {RNA815_14774.1} |
Cumulative graph for MligTC455_39100
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | -4.692 | 1.527 | 1.00000 | 1.00000 | |
| RegionR2 | 0.856 | 1.527 | 0.46190 | 0.84894 | |
| RegionR3 | 1.173 | 1.527 | 0.30331 | 0.84501 | |
| RegionR4 | 3.504 | 1.527 | 0.00509 | 0.03677 | |
| RegionR5 | 2.181 | 1.527 | 0.03899 | 0.15662 | |
| RegionR6 | 1.196 | 1.527 | 0.33189 | 0.92000 | |
| RegionR7 | -3.95 | 1.527 | 1.00000 | 1.00000 | |
| RegionR8 | -0.268 | 1.527 | 0.83050 | 1.00000 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | -0.577 | 1.527 | 0.99993 | 1.00000 | |
| RegenerationR2 | 0.286 | 1.527 | 0.70682 | 0.95858 | |
| RegenerationR3 | 0.793 | 1.527 | 0.40504 | 0.80569 | |
| RegenerationR4 | -0.371 | 1.527 | 0.66142 | 0.93856 | |
| RegenerationR5 | -0.765 | 1.527 | 0.34452 | 0.76048 | |
| RegenerationR6 | -0.082 | 1.527 | 0.92166 | 1.00000 | |
| RegenerationBL | 0.292 | 1.527 | 0.71545 | 1.00000 | |
| RegenerationTP | 2.672 | 1.527 | 0.16918 | 0.60194 |
Genes with expression patterns similar to MligTC455_39100
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_39100 | 62 | 1.29 | Mlig455_009476 | Neo: - Age: Down-Up-Down Region-enriched R4: 3.504/0.03677 |
CABP7 | 4 | - | - | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_009476 {REF} {Length: 960} {Pfam: EF hand [PF00036.34, score=45.6]; EF-hand domain [PF13405.8, score=35.6]; EF-hand domain pair [PF13499.8, score=30.4]; EF-hand domain pair [PF13833.8, score=29.2]; EF hand [PF13202.8, score=28.1]} {Human: ENSG00000100314, CABP7, calcium binding protein 7, [Score=46.6, Expect=1e-05]} {Mouse: ENSMUSG00000009075, Cabp7, calcium binding protein 7, [Score=46.6, Expect=8e-06]} {Celegans: WBGene00015264, B0563.7, Uncharacterized calcium-binding protein B0563.7, [Score=50.4, Expect=3e-07]} {Smed: dd_Smed_v6_13677_0_1, dd_Smed_v6_13677_0_1, [RH, Score=185, Expect=1e-57]} {RNA1509_25282} {RNA1310_29885.1} {RNA815_14774.1} |
| 2. | MligTC455_32561 | 507 | 10.57 | Mlig455_005261 | Neo: - Age: logFC(26M/2M)=-0.281 |
NWD2 | 1.657 | - | - | 0.707 | - | 0.950 | - | Mlig455_005261 {REF} {Length: 6130} {Human: ENSG00000174145, NWD2, NACHT and WD repeat domain containing 2, [Score=172, Expect=3e-42]} {Mouse: ENSMUSG00000090061, Nwd2, NACHT and WD repeat domain containing 2, [Score=159, Expect=2e-38]} {Dmel: FBgn0038397, CG10185, [Score=226, Expect=3e-59]} {Celegans: WBGene00020254, T05C3.2, [Score=233, Expect=3e-61]} {Smed: dd_Smed_v6_9637_0_1, dd_Smed_v6_9637_0_1, [RH, Score=669, Expect=0.0]} {RNA1509_2854, RNA1509_32196, RNA1509_40786} {RNA1310_588, RNA1509_2854, RNA1509_32196, RNA1509_40786} {RNA1509_2854, RNA1509_32196, RNA1509_40786, RNA815_179} |
| 3. | MligTC455_14577 | 51 | 1.06 | Mlig455_024026, Mlig455_024091 | Neo: - Age: logFC(26M/2M)=-0.714 |
0.989 | - | - | - | - | 0.989 | - | Mlig455_024026 {REF} {Length: 243} {NoTransDecoderORF} {RNA1310_72624} Mlig455_024091 {REF} {Length: 2685} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=137.7]} {Smed: dd_Smed_v6_19599_0_1, dd_Smed_v6_19599_0_1, [Score=64.7, Expect=1e-10]} {RNA1310_28762} {RNA815_42177} |
|
| 4. | MligTC455_25671 | 1688 | 35.17 | Mlig455_003489 | Neo: - Age: - Region-enriched R4: 1.264/0.00364 |
SLC15A1 | 0.975 | - | - | - | - | 0.975 | - | Mlig455_003489 {REF} {Length: 5181} {TRANSSPLICED} {Pfam: POT family [PF00854.23, score=324.4]} {Human: ENSG00000088386, SLC15A1, solute carrier family 15 member 1, [RH, Score=424, Expect=8e-138]; ENSG00000163406, SLC15A2, solute carrier family 15 member 2, [RH, Score=405, Expect=2e-130]} {Mouse: ENSMUSG00000022899, Slc15a2, solute carrier family 15 (H+/peptide transporter), member 2, [RH, Score=431, Expect=6e-140]; ENSMUSG00000025557, Slc15a1, solute carrier family 15 (oligopeptide transporter), member 1, [RH, Score=429, Expect=8e-140]} {Dmel: FBgn0028491, CG2930, [RH, Score=429, Expect=6e-139]} {Celegans: WBGene00003876, pept-2, Peptide transporter family 2, [RH, Score=333, Expect=1e-102]} {Smed: dd_Smed_v6_6994_0_1, dd_Smed_v6_6994_0_1, [RH, Score=354, Expect=3e-111]} {RNA1509_5186} {RNA1310_7848} {RNA815_2366.1} |
| 5. | MligTC455_06043 | 3 | 0.06 | Mlig455_056332 | Neo: - Age: - |
0.97 | - | - | - | - | 0.970 | - | Mlig455_056332 {REF} {Length: 356} {NoTransDecoderORF} | |
| 6. | MligTC455_47158 | 42 | 0.88 | Mlig455_002804 | Neo: - Age: - |
0.968 | - | - | - | - | 0.968 | - | Mlig455_002804 {REF} {Length: 2223} {TRANSSPLICED} {RNA1509_26680} {RNA1310_28369.1} {RNA815_11304} | |
| 7. | MligTC455_38997 | 19 | 0.39 | Mlig455_066918 | Neo: - Age: - |
0.965 | - | - | - | - | 0.965 | - | Mlig455_066918 {REF} {Length: 1492} {NoTransDecoderORF} {RNA1509_2373} {RNA1310_20626} {RNA815_9142} | |
| 8. | MligTC455_42103 | 19 | 0.4 | Mlig455_013890 | Neo: - Age: - |
ARID3A | 0.964 | - | - | - | - | 0.964 | - | Mlig455_013890 {REF} {Length: 2772} {Pfam: ARID/BRIGHT DNA binding domain [PF01388.23, score=72.2]} {Human: ENSG00000116017, ARID3A, AT-rich interaction domain 3A, [RH, Score=244, Expect=2e-71]; ENSG00000205143, ARID3C, AT-rich interaction domain 3C, [RH, Score=242, Expect=1e-72]; ENSG00000179361, ARID3B, AT-rich interaction domain 3B, [RH, Score=233, Expect=8e-68]} {Mouse: ENSMUSG00000019564, Arid3a, AT rich interactive domain 3A (BRIGHT-like), [RH, Score=247, Expect=9e-73]; ENSMUSG00000066224, Arid3c, AT rich interactive domain 3C (BRIGHT-like), [RH, Score=245, Expect=2e-74]} {Dmel: FBgn0004795, retn, retained, [RH, Score=241, Expect=2e-68]} {Celegans: WBGene00000476, cfi-1, AT-rich interactive domain-containing protein cfi-1, [RH, Score=231, Expect=3e-68]} {Smed: dd_Smed_v6_13474_0_1, dd_Smed_v6_13474_0_1, [RH, Score=259, Expect=1e-77]} {RNA1509_54880} {RNA1310_44805} {RNA815_49768} |
| 9. | MligTC455_37761 | 12 | 0.26 | Mlig455_014845 | Neo: - Age: - |
0.963 | - | - | - | - | 0.963 | - | Mlig455_014845 {REF} {Length: 2142} {Pfam: CUB domain [PF00431.22, score=21.3]} {RNA1310_77188} | |
| 10. | MligTC455_33637 | 187 | 3.9 | Mlig455_027211, Mlig455_027458 | Neo: - Age: - Region-enriched R2: 3.458/0.04514 |
CHRNA10, CHRNA7 | 0.962 | - | - | - | - | 0.962 | - | Mlig455_027211 {REF} {Length: 782} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=71.6]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=89.4, Expect=4e-20]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=89.4, Expect=4e-20]; ENSG00000166664, CHRFAM7A, CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, [Score=89.0, Expect=2e-20]; ENSG00000275917, CHRFAM7A, CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, [Score=89.0, Expect=1e-20]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=88.6, Expect=7e-20]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=88.6, Expect=7e-20]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=92.0, Expect=4e-21]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=81.6, Expect=9e-18]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=71.6, Expect=2e-14]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=86.3, Expect=1e-19]} {RNA1310_19147.2} {RNA815_8553.2} Mlig455_027458 {REF} {Length: 1493} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=93.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=71.5]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=149, Expect=1e-39]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=148, Expect=1e-39]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=133, Expect=5e-34]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=144, Expect=6e-38]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=144, Expect=7e-38]} {RNA1310_19147.2} {RNA815_8553.2} |
| 11. | MligTC455_15005 | 13 | 0.26 | Mlig455_007503 | Neo: - Age: - |
0.961 | - | - | - | - | 0.961 | - | Mlig455_007503 {REF} {Length: 2488} {Pfam: Immunoglobulin domain [PF13895.8, score=20.5]} {RNA1310_66411} {RNA815_43821} | |
| 12. | MligTC455_43572 | 61 | 1.26 | Mlig455_037945 | Neo: - |
VCX3B | 0.958 | - | - | - | - | 0.958 | - | Mlig455_037945 {REF} {Length: 2194} {Human: ENSG00000205642, VCX3B, variable charge X-linked 3B, [Score=54.7, Expect=8e-09]} {RNA1509_22457} {RNA1310_35286} {RNA815_20576} |
| 13. | MligTC455_19225 | 26 | 0.54 | Mlig455_018507 | Neo: - Age: - |
SCNN1B | 0.957 | - | - | - | - | 0.957 | - | Mlig455_018507 {REF} {Length: 2590} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=142.8]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [Score=59.3, Expect=1e-08]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=60.8, Expect=1e-09]} {Smed: dd_Smed_v6_17245_0_1, dd_Smed_v6_17245_0_1, [Score=49.3, Expect=5e-06]} {RNA1509_52685} {RNA1310_32081} {RNA815_49764} |
| 14. | MligTC455_49211 | 30 | 0.63 | Mlig455_044533 | Neo: - Age: - |
0.955 | - | - | - | - | 0.955 | - | Mlig455_044533 {REF} {Length: 2489} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=139.7]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=62.0, Expect=5e-10]} {Smed: dd_Smed_v6_26469_0_1, dd_Smed_v6_26469_0_1, [Score=51.6, Expect=1e-07]} {RNA1509_50956} {RNA1310_27155} {RNA815_39321} | |
| 15. | MligTC455_14124 | 9 | 0.19 | Mlig455_004227, Mlig455_031052, Mlig455_031059 | Neo: - |
OTOGL, SSPO | 0.952 | - | - | - | - | 0.952 | - | Mlig455_004227 {REF} {Length: 8347} {Pfam: von Willebrand factor type D domain [PF00094.27, score=218.9]; C8 domain [PF08742.13, score=94.5]; Low-density lipoprotein receptor domain class A [PF00057.20, score=62.7]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=52.1]} {Human: ENSG00000197558, SSPO, SCO-spondin, [Score=506, Expect=2e-143]} {Mouse: ENSMUSG00000029797, Sspo, SCO-spondin, [Score=499, Expect=2e-141]} {Dmel: FBgn0029167, Hml, Hemolectin, [Score=327, Expect=5e-89]} {Celegans: WBGene00020481, T13C2.6, [Score=107, Expect=5e-23]} {Smed: dd_Smed_v6_9342_0_1, dd_Smed_v6_9342_0_1, [Score=1126, Expect=0.0]} {RNA1509_11979, RNA1509_44751} {RNA1310_598, RNA1509_44751} {RNA1509_44751, RNA815_582} Mlig455_031052 {REF} {Length: 3393} {Pfam: von Willebrand factor type D domain [PF00094.27, score=117.0]; C8 domain [PF08742.13, score=60.4]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=40.8]} {Human: ENSG00000165899, OTOGL, otogelin like, [Score=200, Expect=1e-51]} {Mouse: ENSMUSG00000001930, Vwf, Von Willebrand factor, [Score=200, Expect=8e-52]; ENSMUSG00000091455, Otogl, otogelin-like, [Score=196, Expect=1e-50]} {Dmel: FBgn0029167, Hml, Hemolectin, [Score=149, Expect=4e-36]} {Smed: dd_Smed_v6_9342_0_1, dd_Smed_v6_9342_0_1, [Score=497, Expect=7e-154]} {RNA1509_47011} {RNA1310_598} {RNA815_582} Mlig455_031059 {REF} {Length: 5292} {Pfam: von Willebrand factor type D domain [PF00094.27, score=221.4]; C8 domain [PF08742.13, score=99.8]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=55.1]; Low-density lipoprotein receptor domain class A [PF00057.20, score=52.2]} {Human: ENSG00000197558, SSPO, SCO-spondin, [Score=489, Expect=4e-142]} {Mouse: ENSMUSG00000029797, Sspo, SCO-spondin, [Score=488, Expect=6e-142]} {Dmel: FBgn0029167, Hml, Hemolectin, [Score=322, Expect=1e-88]} {Celegans: WBGene00003071, lrp-1, Low-density lipoprotein receptor-related protein, [Score=74.7, Expect=6e-13]} {Smed: dd_Smed_v6_9342_0_1, dd_Smed_v6_9342_0_1, [Score=1061, Expect=0.0]} {RNA1509_47011} {RNA1310_598} {RNA815_582} |
| 16. | MligTC455_14139 | 8 | 0.16 | Mlig455_035330 | Neo: - Age: - |
0.951 | - | - | - | - | 0.951 | - | Mlig455_035330 {REF} {Length: 1664} {NoTransDecoderORF} {RNA1509_59348} {RNA1310_114008} {RNA815_45519} |